Smithfield Trust’s Idexx Laboratories IDXX Stock Holding History

Smithfield Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$137K	Hold	243	–	–	0.01%	431
2025 Q4	$164K	Buy	243 +7	+3%	+$4.77K	0.01%	390
2025 Q3	$151K	Hold	236	–	–	0.01%	384
2025 Q2	$128K	Hold	236	–	–	0.01%	409
2025 Q1	$99K	Sell	236 -2	-0.8%	-$868	0.01%	442
2024 Q4	$98K	Hold	238	–	–	﹤0.01%	450
2024 Q3	$121K	Hold	238	–	–	0.01%	425
2024 Q2	$115K	Hold	238	–	–	0.01%	413
2024 Q1	$129K	Hold	238	–	–	0.01%	406
2023 Q4	$133K	Hold	238	–	–	0.01%	375
2023 Q3	$104K	Hold	238	–	–	0.01%	407
2023 Q2	$121K	Hold	238	–	–	0.01%	388
2023 Q1	$121K	Hold	238	–	–	0.01%	380
2022 Q4	$96K	Sell	238 -8	-3%	-$3.1K	0.01%	406
2022 Q3	$82K	Hold	246	–	–	0.01%	426
2022 Q2	$89K	Hold	246	–	–	0.01%	436
2022 Q1	$133K	Hold	246	–	–	0.01%	375
2021 Q4	$162K	Hold	246	–	–	0.01%	362
2021 Q3	$152K	Hold	246	–	–	0.01%	359
2021 Q2	$155K	Hold	246	–	–	0.01%	357
2021 Q1	$121K	Hold	246	–	–	0.01%	402
2020 Q4	$122K	Buy	246 +22	+10%	+$9.84K	0.01%	399
2020 Q3	$88K	Buy	224 +69	+45%	+$25.5K	0.01%	419
2020 Q2	$51K	Buy	155 +72	+87%	+$20.8K	﹤0.01%	480
2020 Q1	$20K	Hold	83	–	–	﹤0.01%	574
2019 Q4	$21K	Hold	83	–	–	﹤0.01%	621
2019 Q3	$23K	Hold	83	–	–	﹤0.01%	632
2019 Q2	$23K	Hold	83	–	–	﹤0.01%	617
2019 Q1	$19K	Hold	83	–	–	﹤0.01%	596
2018 Q4	$15K	Hold	83	–	–	﹤0.01%	604
2018 Q3	$21K	Hold	83	–	–	﹤0.01%	636
2018 Q2	$18K	Buy	83 +43	+108%	+$8.86K	﹤0.01%	662
2018 Q1	$8K	Hold	40	–	–	﹤0.01%	755
2017 Q4	$6K	Buy	+40	New	+$6.3K	﹤0.01%	820
2017 Q1	–	Sell	-300	Closed	-$35K	–	795
2016 Q4	$35K	Hold	300	–	–	0.01%	565
2016 Q3	$34K	Hold	300	–	–	0.01%	567
2016 Q2	$28K	Hold	300	–	–	0.01%	572
2016 Q1	$23K	Hold	300	–	–	﹤0.01%	593
2015 Q4	$22K	Hold	300	–	–	﹤0.01%	600
2015 Q3	$22K	Hold	300	–	–	﹤0.01%	595
2015 Q2	$19K	Hold	300	–	–	﹤0.01%	637
2015 Q1	$23K	Hold	300	–	–	﹤0.01%	621
2014 Q4	$22K	Hold	300	–	–	﹤0.01%	613
2014 Q3	$18K	Hold	300	–	–	﹤0.01%	653
2014 Q2	$20K	Hold	300	–	–	﹤0.01%	651
2014 Q1	$18K	Hold	300	–	–	﹤0.01%	648
2013 Q4	$16K	Hold	300	–	–	﹤0.01%	639
2013 Q3	$15K	Hold	300	–	–	﹤0.01%	610
2013 Q2	$13K	Buy	+300	New	+$13.1K	﹤0.01%	614

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Smithfield Trust's IDXX Position: Q1 2026 in Review

Smithfield Trust held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 243 shares worth $137K. The position accounts for 0.01% of the portfolio, ranked #431.

Smithfield Trust first reported a position in IDXX in Q2 2013 and has held it in 49 quarters since. The position peaked at $164K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Smithfield Trust held 243 shares of Idexx Laboratories worth $137K as of Q1 2026.
Smithfield Trust left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #431 holding.
Smithfield Trust first reported a position in Idexx Laboratories in Q2 2013 and has held it in 49 quarters since.
Smithfield Trust's Idexx Laboratories position peaked at $164K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.